Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival.
Jana S HopstakenPauline A J VissersRutger QuispelJudith De Vos-GeelenLodewijk A A BrosensIgnace H J T de HinghLydia G M van der GeestMarc G H BesselinkKees J H M van LaarhovenMartijn Willem Jan StommelPublished in: BJS open (2023)
In this nationwide analysis, network treatment in patients with resected pancreatic cancer was not associated with longer time to chemotherapy, failure to complete adjuvant chemotherapy, and worse survival. Significant variation between pancreatic cancer networks was found for time to chemotherapy.